NCT00804921View on ClinicalTrials.gov

Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Macular EdemaDiabetic RetinopathyMacular Degeneration
Interventions
DRUG

bevacizumab

PROCEDURE

anterior chamber paracentesis

DRUG

acetazolamide

DRUG

brimonidine

Trial Locations (1)

14049-900

School of Medicine - Clinical Hospital, Ribeirão Preto

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT00804921 - Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab | Biotech Hunter | Biotech Hunter